These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 27764976)

  • 1. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
    Yoon CY; Chang TI; Kang EW; Lim BJ; Kie JH; Kee YK; Kim H; Park S; Yun HR; Jung SY; Jhee JH; Kwon YE; Oh HJ; Park JT; Yoo TH; Kang SW; Jeong HJ; Han SH
    Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
    Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of immunosuppression in IgA nephropathy based on the oxford classification.
    Palamuthusingam D; Castledine C; Lawman S
    Saudi J Kidney Dis Transpl; 2018; 29(2):341-350. PubMed ID: 29657202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
    Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy.
    Park S; Kim HW; Park JT; Chang TI; Kang EW; Ryu DR; Yoo TH; Chin HJ; Jeong HJ; Kang SW; Lim BJ; Han SH
    Nephrol Dial Transplant; 2020 Dec; 35(12):2103-2137. PubMed ID: 31377783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy.
    Kang SH; Choi SR; Park HS; Lee JY; Sun IO; Hwang HS; Chung BH; Park CW; Yang CW; Kim YS; Choi YJ; Choi BS
    Nephrol Dial Transplant; 2012 Jan; 27(1):252-8. PubMed ID: 21606384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
    BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V; Troyanov S; Bellur S; Verhave JC; Cook HT; Feehally J; Roberts IS; Cattran D; Coppo R;
    J Am Soc Nephrol; 2015 Sep; 26(9):2248-58. PubMed ID: 25677392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
    Bellur SS; Roberts ISD; Troyanov S; Royal V; Coppo R; Cook HT; Cattran D; Arce Terroba Y; Asunis AM; Bajema I; Bertoni E; Bruijn JA; Cannata-Ortiz P; Casartelli D; Maria Di Palma A; Ferrario F; Fortunato M; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Giannakakis K; Gomà M; Gröne HJ; Gutiérrez E; Asma Haider S; Honsova E; Ioachim E; Karkoszka H; Kipgen D; Maldyk J; Mazzucco G; Orhan D; Ozluk Y; Pantzaki A; Perkowska-Ptasinska A; Riispere Z; Soderberg MP; Steenbergen E; Stoppacciaro A; Sundelin Von Feilitzen B; Tardanico R
    Nephrol Dial Transplant; 2019 Oct; 34(10):1681-1690. PubMed ID: 30561721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
    J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS;
    Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy.
    Yu F; Zhu X; Yuan S; Chen X; Li Z; Qu Z; Liu H; Sun L; Liu F
    Ann Med; 2021 Dec; 53(1):587-595. PubMed ID: 33825605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the Oxford classification of IgA nephropathy to predict renal survival.
    Alamartine E; Sauron C; Laurent B; Sury A; Seffert A; Mariat C
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2384-8. PubMed ID: 21885791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA nephropathy: an update.
    Soares MF; Roberts IS
    Curr Opin Nephrol Hypertens; 2017 May; 26(3):165-171. PubMed ID: 28221174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
    Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.